Ridgeland

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Type 2 diabetes2 trials

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• AstraZeneca3 trials

Running trials

• Recruiting

  A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  NCT07662109· Phase 3· AstraZeneca· Source

• Recruiting

  A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

  NCT07667803· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes2 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

  NCT06595238· Phase 2· AstraZeneca· Source